Equity
€1.0m ▲ 1.4%
DR. ISABELLE LAMBERT paid out €104,585 in dividends. That is 88% of the 2025 profit.
DR. ISABELLE LAMBERT
Lifetime
15 annual accounts with figures on one time axispeak €328,684 (2020)
€150,059▲ 39.0%
peak €224,089 (2020)
€118,703▲ 28.6%
peak €1.2m (2020)
€1.0m▲ 1.4%
€46,866▲ 4.6%
Board1 name since 2022
1 directorIsabelle Lambert
Documentsfilings and deeds
30-04-202692 days before the deadline
2025micro format
Gross margin from €107,930 to €150,059Result from €92,331 to €118,703Dividend €104,585Cash from €94,523 to €136,841
Key points
from the 2025 annual accountsFilings
15 annual accounts since 2011
The last five annual accounts were filed 5 to 122 days before the end of the period.
Position in the sector
€1.0m
More equity than 94% of companies in human health. Sector median €124,628 · 20,776 companies.
Checked score
94
Excellent
Financially stronger than 50% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025highest value
06-2025: < 0.1%● unchanged vs 05-2025highest value
07-2025: < 0.1%● unchanged vs 06-2025highest value
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026lowest value
10-2026: < 0.1%● unchanged vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Figures for financial year 2025 (filed on 30-04-2026)
Size: total assets €1.1m
Equity €1.0m (95.7% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 45% on liquidity, 30% on profitability and 41% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 17,811 companies had the same profile as DR. ISABELLE LAMBERT has now. Each dot stands for 45 companies, two years later.
96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
That fits the bankruptcy probability of DR. ISABELLE LAMBERT itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 17,811 companies, not a prediction for DR. ISABELLE LAMBERT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €95,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 24.12 (24.83 in 2024), above the usual 1.5. Short-term debt is 4.1% and cash 12.5% of total assets. 4.3% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
5 signals, none raises the risk
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-04-2026, 92 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
92 days early
2024
122 days early
2023
84 days early
2022
81 days early
2021
5 days early
2020
45 days early
2019
64 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 70 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 9 May (4 of the last 5 accounts filed within 39 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0832760440
Legal-form change · Resignations & appointments
Registered office clause: Hagewegel 7 · General meeting of 30-06-2023 · Gazette deed
Reappointment: Isabelle Lambert (director)
General meeting of 30-06-2022 · Gazette deed
Incorporation
published on 25-01-2011 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DR. ISABELLE LAMBERT Lokeren | €1.1m | €150,059 | 95.7% | - |
| DOKTER HERLINDE LAMOTE, PSYCHIATRIE Kortrijk | €1.1m | €157,151 | 92.1% | - |
| DR. MUYLAERT SOFIE, PSYCHIATER Zedelgem | €1.2m | €148,189 | 86.5% | - |
| Dr. Katie WOLLAERT Schilde | €1.0m | €162,639 | 73.3% | - |
| CABINET MEDICAL Dr CIELNIASZEK Blegny | €1.1m | €169,798 | 30.1% | - |
| J.M. MEDICAL Sint-Genesius-Rode | €1.1m | €132,369 | 59.8% | - |
| Dokter VERDONCK KRISTOFF (geneesheer - specialist) - Plastische heelkunde Tessenderlo-Ham | €1.1m | €130,454 | 44.6% | - |
These companies have the same main activity as DR. ISABELLE LAMBERT: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1m and €1.2m, founded between 2009 and 2011.
Official details
Source: KBO- Status
- Active since 12-01-2011Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.195.853.6339160 Lokeren, since 12-01-2011
- Financial year end
- 31 December
- Peppol
- Reachable since 27-03-2025
Annual accounts 2025
- ≈ €280,000estimated
- €1.1m▲ 1.5%
- Filing
- Filed on 30-04-2026, 92 days before the end of the filing period
Insights on DR. ISABELLE LAMBERT
DR. ISABELLE LAMBERT files the micro format. That format states no turnover. The gross margin fell from €170,830 in 2011 to €150,059 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DR. ISABELLE LAMBERT
- What is the company number of DR. ISABELLE LAMBERT?
- The company number of DR. ISABELLE LAMBERT is 0832.760.440. The VAT number is the same number with BE in front: BE 0832.760.440.
- Where is DR. ISABELLE LAMBERT based?
- The registered office is at Hagewegel 7, 9160 Lokeren.Company details
- What does DR. ISABELLE LAMBERT do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DR. ISABELLE LAMBERT?
- DR. ISABELLE LAMBERT is a private limited company (BV).
- When was DR. ISABELLE LAMBERT founded?
- DR. ISABELLE LAMBERT was founded on 12-01-2011.
- Is DR. ISABELLE LAMBERT still active?
- Yes, DR. ISABELLE LAMBERT is an active enterprise in the KBO register.
- What is the turnover of DR. ISABELLE LAMBERT?
- The turnover in financial year 2025 is ≈ €280,000. This figure is estimated from the gross margin of €150,059 and 41 comparable companies (NACE 86220). It probably lies between €240,000 and €370,000.Financials
- Is DR. ISABELLE LAMBERT profitable?
- In financial year 2025, DR. ISABELLE LAMBERT made a profit of €118,703.
- Where can I find the annual accounts of DR. ISABELLE LAMBERT?
- DR. ISABELLE LAMBERT filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR. ISABELLE LAMBERT due?
- DR. ISABELLE LAMBERT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.